Clinical Trial

A Randomized Trial of Six-Channel RF Ablation System for Renal Denervation in Uncontrolled Hypertension and Chronic Kidney Disease

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
Prospective, Multi-Center, Randomized, Parallel-Controlled, Uptake clinical trial to evaluate the efficacy and safety of the six-channel radiofrequency(RF) renal denervation system-comprising the six-channel radiofrequency generator (specification model: 25D1G, software release version: SRG-V1) and the disposable ultra-guiding radiofrequency denervation catheter (specification model: 25C6W127F115T)-for renal denervation in patients with uncontrolled hypertension and chronic kidney disease.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-18.
Trial Details
NCT Number NCT07130955
Lead Sponsor Shanghai Golden Leaf MedTec Co. Ltd
Collaborators: Beijing Anzhen Hospital, Shanghai Zhongshan Hospital, Guangdong Provincial People's Hospital, The Second Affiliated Hospital of Harbin Medical University, West China Hospital, Jiangxi Provincial People's Hopital, Navy General Hospital, Beijing, Qilu Hospital of Shandong University, Xijing Hospital, Fujian Provincial Hospital, First Affiliated Hospital of Fujian Medical University, Henan Provincial People's Hospital, Hebei Provincial People's Hospital, Anhui Provincial Hospital, The First Hospital of Jilin University, First Affiliated Hospital of Xinjiang Medical University, First Affiliated Hospital of Guangxi Medical University, Qianfoshan Hospital, Ningbo Medical Center Lihuili Hospital, Mianyang Central Hospital, The Third People's Hospital of Chengdu, General Hospital of the Eastern Theater Command, China-Japan Union Hospital, Jilin University, Shanxi Bethune Hospital, Second Hospital of Shanxi Medical University, Yan'an Affiliated Hospital of Kunming Medical University
Conditions Hypertension, CKD - Chronic Kidney Disease
Enrollment 236 participants
Start Date 2025-08-08
Primary Completion 2026-12-30 (estimated)
Study Completion 2030-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-02-11